Graham Craig
Graham Craig is Chief Commercial Officer at VoxCell BioInnovation, where he leads commercial partnerships with pharmaceutical companies and contract research organisations seeking to integrate human-relevant tissue models into preclinical workflows. With 18 years in the pharmaceutical and biotechnology sectors, he focuses on bringing advanced platforms, including vascularised 3D tissue models, into routine use in drug development.
ArticleWhy targeted therapies are exposing the limits of animal models – and what comes next
Traditional preclinical models are struggling to keep pace with a new generation of targeted therapies. As regulators embrace new approach methodologies (NAMs), vascularised tissue platforms are offering a more human-relevant approach to predicting drug efficacy and safety.